Nutrition Research and Practice

The Korean Nutrition Society (한국영양학회)
권호 표지

The associations between serum leptin, adiponectin and intercellular adhesion molecule-1 in hypercholesterolemic patients

  • Park, Eun-Ju (Department of Food and Nutrition, Kyungnam University) ;
  • Shin, Min-Jeong (Yonsei Cardiovascular Research Institute, Yonsei University College of Medicine) ;
  • Chung, Nam-Sik (Yonsei Cardiovascular Research Institute, Yonsei University College of Medicine)
  • Published : 2007.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

We examined the associations between adiponectin or leptin and serum ICAM-1 levels in seventy-six hypercholesterolemic patients (mean age 59 yrs, 25 males and 51 females, LDL-cholesterol>=130mg/dL at screening). Blood lipid profiles and HOMA-IR derived from fasting glucose and insulin concentrations were determined. Serum levels of adiponectin, leptin and ICAM-1 were analyzed using ELISA The results showed that serum levels of leptin were positively associated with serum levels of ICAM-1 independent of age, sex and BMI (r=0.392, p<0.001). Serum levels of adiponectin were negatively associated with serum levels of ICAM-1 independent of age, sex and BMI (r=-0.343, p<0.005). Stepwise multiple linear regression analysis showed that serum leptin was an independent factor to be associated with serum ICAM-1 levels after adjusting for age, sex, BMI, alcohol intake, smoking status, blood lipids such as total cholesterol, triglyceride, HDL cholesterol and LDL cholesterol and HOMA-IR (p<0.001). With respect to adiponectin, its association with serum ICAM-1 was attenuated but still significant when further adjustments were made for age, sex, BMI, alcohol intake, smoking status, blood lipids such as total cholesterol, triglyceride, HDL cholesterol and LDL cholesterol and HOMA-IR (p<0.005). In conclusion, this study suggests that adiponectin and leptin are associated with endothelial derived inflammation.

Keywords

References

  1. Ahima RS (2005). Central actions of adipocyte hormones. Trends Endocrinol Metab 16:307-313 https://doi.org/10.1016/j.tem.2005.07.010
  2. Berg AH, Combs TP, Du X, Brownlee M & Scherer PE (2001). The adipocyte secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953 https://doi.org/10.1038/90992
  3. Berg AH & Scherer PE (2005). Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96:939-949 https://doi.org/10.1161/01.RES.0000163635.62927.34
  4. Chan JL, Bullen J, Stoyneva V, Depaoli AM, Addy C & Mantzoros CS (2005). Recombinant methionyl human leptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excess. J Clin Endocrinol Metab 90:1618-1624 https://doi.org/10.1210/jc.2004-1921
  5. Chandran M, Ciaraldi T, Philips SA & Henry RR (2003). Adiponectin: more than just another fat cell hormone? Diabetes Care 26:2442-2450 https://doi.org/10.2337/diacare.26.8.2442
  6. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM & Stern DM (1998). Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527-3561
  7. de Courten M, Zimmet P, Hodge A, Collins V, Nicolson M & Staten M (1997). Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med 14:200-208 https://doi.org/10.1002/(SICI)1096-9136(199703)14:3<200::AID-DIA336>3.0.CO;2-V
  8. Fantuzzi G (2005). Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911-919 https://doi.org/10.1016/j.jaci.2005.02.023
  9. Glowinska B, Urban M, Peczynska J & Florys B (2005). Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism 54:1020-1026 https://doi.org/10.1016/j.metabol.2005.03.004
  10. Hackman A, Abe Y, Insull W Jr, Pownall H, Smith L, Dunn K, Gotto AM Jr & Ballantyne CM (1996). Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 93:1334-1338 https://doi.org/10.1161/01.CIR.93.7.1334
  11. Hopkins AM, Baird AW & Nusrat A (2004). ICAM-1: targeted docking for exogenous as well as endogenous ligands. Adv Drug Deliv Rev 56:763-778 https://doi.org/10.1016/j.addr.2003.10.043
  12. Hu E, Liang P & Spiegelman BM (1996). Adipo Q is a novel adipo-specific gene dysregulated in obesity. J Biol Chem 271: 10697-10703 https://doi.org/10.1074/jbc.271.18.10697
  13. Ikata J, Wakatsuki T, Oishi Y, Oki T & Ito S (2004). Leukocyte counts and concentrations of soluble adhesion molecules as predictors of coronary atherosclerosis. Coron Artery Dis 11:445-449 https://doi.org/10.1097/00019501-200009000-00001
  14. Karaduman M, Sengul A, Oktenli C, Pekel A, Yesilova Z, Musabak U, Sanisoglu SY, Gunay C, Baysan O, Kocar IH, Tatar H & Ozata M (2006). Tissue levels of adiponectin, tumour necrosis factoralpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques. Clin Endocrinol (Oxf) 64:196-202 https://doi.org/10.1111/j.1365-2265.2006.02448.x
  15. Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, Manabe I, Utsunomiya K & Nagai R (2004). Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 314:415-419 https://doi.org/10.1016/j.bbrc.2003.12.104
  16. Kent JW Jr, Comuzzie AG, Mahaney MC, Almasy L, Rainwater DL, VandeBerg JL, MacCluer JW & Blangero J (2004). Intercellular adhesion molecule-1 concentration is genetically correlated with insulin resistance, obesity, and HDL concentration in Mexican Americans. Diabetes 53:2691-2695 https://doi.org/10.2337/diabetes.53.10.2691
  17. Kevil CG, Patel RP & Bullard DC (2004). Essential role of ICAM-1 in mediating monocyte adhesion to aortic endothelial cells. Am J Physiol Cell Physiol 281:C1442-1447
  18. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB & Chen C (2005). Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res 126:121-129 https://doi.org/10.1016/j.jss.2004.12.023
  19. Lau DC, Dhillon B, Yan H, Szmitko PE & Verma S (2005). Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 288:H2031-2041 https://doi.org/10.1152/ajpheart.01058.2004
  20. Libby P, Ridker PM & Maseri A (2002). Inflammation and atherosclerosis. Circulation 105:1135-1143 https://doi.org/10.1161/hc0902.104353
  21. Libby P (2002). Inflammation in atherosclerosis. Nature 420:868-874 https://doi.org/10.1038/nature01323
  22. Lyon CJ, Law RE & Hsueh WA (2003). Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144:2195-2200 https://doi.org/10.1210/en.2003-0285
  23. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC (1985). Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 https://doi.org/10.1007/BF00280883
  24. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, Terasaka N, Inaba T, Funahashi T & Matsuzawa Y (2002). Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106:2767-2770 https://doi.org/10.1161/01.CIR.0000042707.50032.19
  25. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T & Matsuzawa Y (1999). Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100:2473-2476 https://doi.org/10.1161/01.CIR.100.25.2473
  26. Peelman F, Waelput W, Iserentant H, Lavens D, Eyckerman S, Zabeau L & Tavernier J (2004). Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases. Prog Lipid Res 43:283-301 https://doi.org/10.1016/j.plipres.2004.03.001
  27. Skilton MR, Nakhla S, Sieveking DP, Caterson ID & Celermajer DS (2005). Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells. Clin Exp Pharmacol Physiol 32:839-844 https://doi.org/10.1111/j.1440-1681.2005.04274.x
  28. van de Stolpe A & van der Saag PT (1996). Intercellular adhesion molecule-1. J Mol Med 74:13-33 https://doi.org/10.1007/BF00202069
  29. van der Vleuten GM, Veerkamp MJ, van Tits LJ, Toenhake H, den Heijer M, Stalenhoef AF & de Graaf J (2005). Elevated leptin levels in subjects with familial combined hyperlipidemia are associated with the increased risk for CVD. Atherosclerosis 183:355-360 https://doi.org/10.1016/j.atherosclerosis.2005.03.019
  30. van der Vleuten GM, van Tits LJ, den Heijer M, Lemmers H, Stalenhoef AF & de Graaf J (2005). Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile. J Lipid Res 46:2398-2404 https://doi.org/10.1194/jlr.M500212-JLR200
  31. van Haelst PL, van Doormaal JJ, Asselbergs FW, van Roon AM, Veeger NJ, Henneman MM, Smit AJ, Tervaert JW, May JF & Gans RO (2003). Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia. Clin Sci (Lond) 104:627-632 https://doi.org/10.1042/CS20020293
  32. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A & Sattar N (2001). Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104:3052-3056 https://doi.org/10.1161/hc5001.101061
  33. Witkowska AM (2005). Soluble ICAM-1: a marker of vascular inflammation and lifestyle. Cytokine 31:127-134 https://doi.org/10.1016/j.cyto.2005.04.007
  34. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K & Matsui J (2003). Globular adiponectin protected ob/ob mice from diabetes and ApoEdeficient mice from atherosclerosis. J Biol Chem 278:2461-2468 https://doi.org/10.1074/jbc.M209033200
  35. Zeitler H, Ko Y, Zimmermann C, Nickenig G, Glanzer K, Walger P, Sachinidis A & Vetter H (1997). Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction. Eur J Med Res 2:389-394
  36. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM & Giugliano D (2002). Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105:804-809 https://doi.org/10.1161/hc0702.104279
  37. Zimmet P, Hodge A, Nicolson M, Staten M, de Courten M, Moore J, Morawiecki A, Lubina J, Collier G, Alberti G & Dowse G (1996). Serum leptin concentration, obesity and insulin resistance in Western cross sectional study. Br Med J 313:965-969 https://doi.org/10.1136/bmj.313.7063.965